Jonah Berger
Wharton Marketing Professor | Bestselling Author of Contagious, The Catalyst & Magic Words | Expert on Viral Marketing, Influence & Persuasion
2013 Nobel Laureate in Physiology or Medicine | Avram Goldstein Professor, Stanford University | Pioneer of Synaptic Neuroscience
Few scientists have reshaped our understanding of the brain as profoundly as Nobel Laureate Thomas Südhof. His discovery of the molecular machinery governing neurotransmitter release earned him the 2013 Nobel Prize in Physiology or Medicine and laid the foundation for new approaches to Alzheimer's, autism, and schizophrenia. At Stanford, he continues pushing the frontier of synapse biology — and in his keynotes, translates that science into insights that matter to medicine, biotech, and beyond.
Want to book Thomas Südhof as a speaker for your event? Please provide the info below and we’ll get in touch within 24h:
Thomas C. Südhof is one of the most consequential neuroscientists alive, whose discoveries have fundamentally changed how medicine understands the brain. Born in Göttingen, Germany, he earned both his M.D. and doctoral degrees from the University of Göttingen before moving to the United States to train under Nobel laureates Michael Brown and Joseph Goldstein at UT Southwestern Medical Center in Dallas — two mentors who would themselves win the Nobel Prize in Physiology or Medicine while Südhof was in their lab.
Nobel Prize speaker Thomas Südhof spent over two decades at UT Southwestern, where he founded and chaired the Department of Neuroscience and built one of the world’s leading synaptic biology programs. In 2008, he joined Stanford University, where he holds the Avram Goldstein Professorship in the School of Medicine and serves as an investigator of the Howard Hughes Medical Institute — a position he has held continuously since 1986. His laboratory focuses on how synapses form, how their properties are specified, and how genetic mutations cause them to break down in conditions such as Alzheimer’s disease, autism, schizophrenia, and epilepsy.
In 2013, Südhof was awarded the Nobel Prize in Physiology or Medicine, shared with James Rothman and Randy Schekman, for discoveries that revealed the molecular machinery controlling vesicle trafficking — the precise cellular process by which neurons release neurotransmitters at exactly the right moment, enabling the brain to think, feel, and act. His identification of synaptotagmins as calcium sensors for neurotransmitter release was a landmark insight that took over a decade to become fully accepted and remains foundational to modern neuroscience. Beyond the Nobel, he has received the Albert Lasker Basic Medical Research Award, the Kavli Prize in Neuroscience, and the Passano Award, among many others. He is an elected member of the National Academy of Sciences, the American Academy of Arts and Sciences, and the Royal Society of the UK.
As a speaker, Thomas Südhof brings the intellectual authority of a Nobel laureate combined with the rare ability to translate molecular neuroscience into frameworks that matter to healthcare executives, policymakers, biotech investors, and research leaders. His talks explore how the brain’s synaptic architecture underpins neurological and psychiatric disease, why breakthroughs in synapse biology are opening new therapeutic windows for Alzheimer’s and autism, and what the future of brain medicine looks like as neuroscience and technology converge. Audiences gain a deep, evidence-grounded perspective on the most consequential frontier in human health from the scientist who helped define it.
Every thought, memory, and emotion depends on the precise transmission of signals between neurons. In this keynote, Südhof traces the science behind synaptic communication — from the discovery of vesicle trafficking machinery to the calcium sensors that trigger neurotransmitter release — and explains why this molecular choreography is so central to both healthy brain function and the onset of neurological disease. Audiences leave with a new appreciation for what makes the brain work, and what happens when it doesn't.
Some of the most devastating and least understood diseases of our time — Alzheimer's, schizophrenia, autism spectrum disorder — share a common root: the breakdown of synaptic function. Südhof draws on decades of research and the latest findings from his Stanford laboratory to explain how genetic mutations disrupt synapse formation and specification, and why this understanding is opening genuinely new therapeutic windows. A compelling talk for healthcare executives, biomedical investors, and research leaders navigating the future of brain medicine.
The molecular insights that won Thomas Südhof the Nobel Prize began as pure curiosity-driven research with no obvious commercial application — and eventually transformed neuroscience and created entirely new fields of therapeutic development. In this talk, Südhof reflects on the long arc from fundamental discovery to clinical and industrial impact, making the case for sustained investment in basic research and explaining how academic science and the biotech industry can collaborate more effectively to address unmet medical needs.
The brain is not born fully wired — it builds itself through a process of synapse formation that is only now beginning to be understood at the molecular level. Südhof presents cutting-edge research on how neurons establish specific connections, how synaptic identity is encoded, and why errors in this process during development underlie many neuropsychiatric conditions. Delivered with the rigor of a world-leading laboratory scientist and the clarity of an experienced speaker, this talk challenges audiences to think differently about brain development and its implications for medicine and human potential.
| Basic Data Protection Information | |
|---|---|
| Data controller | AURUM SPEAKERS BUREAU S.L. |
| Address | Parc Audiovisual de Catalunya 1, Oficina S11, 08225 Terrassa, Spain |
| Purposes | We will use your data to respond to your requests and deliver our services to you. |
| Marketing | We will only send you marketing correspondence if you have given your prior consent, which you can do by ticking the box for that purpose. |
| Lawful basis | We will only process your data if you have given your prior consent, which you can do by ticking the box for that purpose. |
| Recipients | Generally, only our members of staff who have been duly authorised may access the data that you have provided. |
| Your Rights | You have the right to know what information we hold about you, to rectify it and to erase it, as explained in the additional information available on our website. |
| Additional Information | For more information, please see “PRIVACY POLICY” on our website. |